control fat (cf) diet Search Results


high fat diet hfd  (Valiant Co Ltd)
94
Valiant Co Ltd high fat diet hfd
High Fat Diet Hfd, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/Fat+diet/pmc12309502-112-41-85
Average 94 stars, based on 1 article reviews
high fat diet hfd - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
testdiet 58g7  (PMI Nutrition International LLC)
94
PMI Nutrition International LLC testdiet 58g7
AGE content in mouse diets.
Testdiet 58g7, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/Basal+Purified+Diet+w%2F+12%25+Energy+From+Fat+(Control)+58G7/pmc03319631-0-0-0
Average 94 stars, based on 1 article reviews
testdiet 58g7 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
hfd  (Valiant Co Ltd)
90
Valiant Co Ltd hfd
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Hfd, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/Fat+Diet+With+60+kcal%25/pm39182019-57-54-60
Average 90 stars, based on 1 article reviews
hfd - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
fat free diet  (Valiant Co Ltd)
94
Valiant Co Ltd fat free diet
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Fat Free Diet, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/Fat+free+diet/10__1172_slash_jci42894-317-14-17
Average 94 stars, based on 1 article reviews
fat free diet - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
control diet  (PMI Nutrition International LLC)
94
PMI Nutrition International LLC control diet
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Control Diet, supplied by PMI Nutrition International LLC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/AIN-93G+Low+Fat+Control+for+Western+Diet+(Control)+5TJS/10__1249_slash_mss__0000000000002105-55-10-12
Average 94 stars, based on 1 article reviews
control diet - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
choline replete control diet  (Valiant Co Ltd)
96
Valiant Co Ltd choline replete control diet
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Choline Replete Control Diet, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/Choline+control+diet/bio_rxiv__64898__2026__02__05__703880-202-28-32
Average 96 stars, based on 1 article reviews
choline replete control diet - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
low fat control diet lf d14110101  (research diets inc)
90
research diets inc low fat control diet lf d14110101
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Low Fat Control Diet Lf D14110101, supplied by research diets inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/low+fat+control+diet+lf+d14110101/pm32259599-56-30-40
Average 90 stars, based on 1 article reviews
low fat control diet lf d14110101 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
low-fat diet e15051 ef r/m  (ssniff Spezialdiaten)
90
ssniff Spezialdiaten low-fat diet e15051 ef r/m
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Low Fat Diet E15051 Ef R/M, supplied by ssniff Spezialdiaten, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/low+fat+control+diet/pmc07497324-35-0-5
Average 90 stars, based on 1 article reviews
low-fat diet e15051 ef r/m - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
powder-based low-fat control chow diet  (GENTAUR Inc)
90
GENTAUR Inc powder-based low-fat control chow diet
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Powder Based Low Fat Control Chow Diet, supplied by GENTAUR Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/powder+based+low+fat+control+chow+diet/pm38672446-31-24-43
Average 90 stars, based on 1 article reviews
powder-based low-fat control chow diet - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
low-fat, no-cholesterol rodent chow (i.e., the control diet)  (Bio-Serv)
90
Bio-Serv low-fat, no-cholesterol rodent chow (i.e., the control diet)
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Low Fat, No Cholesterol Rodent Chow (I.E., The Control Diet), supplied by Bio-Serv, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/low+fat++no+cholesterol+rodent+chow++i+e+++the+control+diet+/pm22508243-37-2-12
Average 90 stars, based on 1 article reviews
low-fat, no-cholesterol rodent chow (i.e., the control diet) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
control fat (cf) diet  (research diets inc)
90
research diets inc control fat (cf) diet
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Control Fat (Cf) Diet, supplied by research diets inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/control+fat++cf++diet/pm30990747-42-17-50
Average 90 stars, based on 1 article reviews
control fat (cf) diet - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
certified diets control rodent diet with 10% of total calories as fat  (research diets inc)
90
research diets inc certified diets control rodent diet with 10% of total calories as fat
Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; <t>HFD,</t> <t>high-fat</t> <t>diet;</t> <t>AUC,</t> area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet
Certified Diets Control Rodent Diet With 10% Of Total Calories As Fat, supplied by research diets inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+fat+(cf)+diet/certified+diets+control+rodent+diet+with+10++of+total+calories+as+fat/pm37630722-72-0-6
Average 90 stars, based on 1 article reviews
certified diets control rodent diet with 10% of total calories as fat - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


AGE content in mouse diets.

Journal: PLoS ONE

Article Title: Effect of Dietary Advanced Glycation End Products on Mouse Liver

doi: 10.1371/journal.pone.0035143

Figure Lengend Snippet: AGE content in mouse diets.

Article Snippet: TestDiet 58G7 , 60649±1147 , 1107±39.

Techniques:

Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; HFD, high-fat diet; AUC, area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Journal: Genes & nutrition

Article Title: Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism.

doi: 10.1186/s12263-024-00754-5

Figure Lengend Snippet: Fig. 2 Nogo-B deficiency alleviates weight gain and impaired glucose tolerance in NAFLD model mice. (A) Photos of the mice and their livers at the end of the 12-week experiment; (B) body weight (weekly); (C) body weight (last measurement); (D) liver weight (last measurement); (E) glucose tolerance test (GTT); (F) AUC of the GTT; (G) insulin tolerance test (ITT); (H) AUC of the ITT. n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. NCD, normal chow diet; HFD, high-fat diet; AUC, area under the curve; BMDMs, bone marrow-derived macrophages; WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Article Snippet: Following an 8-week period of standard growth, 12 WT mice and 12 Nogo-B−/− mice were randomly divided into the normal chow diet (NCD) or high-fat diet (HFD) groups, which were reared in a barrier system at temperatures ranging from 20 to 26 °C and fed either the NCD (SPF (Beijing) Biotechnology Co., Ltd.) or HFD (fat diet with 60 kcal%, MP Biomedicals, LLC) for 12 weeks.

Techniques: Derivative Assay

Fig. 3 Nogo-B deficiency mitigates liver lipid accumulation and liver injury in NAFLD model mice. (A) Serum triacylglycerol (TG); (B) serum total cholester ol (TC); (C) serum low-density lipoprotein cholesterol (LDL-C); (D) serum high-density lipoprotein cholesterol (HDL-C); (E) serum alanine aminotransferase (ALT); (F) serum aspartate aminotransferase (AST); (G) serum alkaline phosphatase (ALP); (H) serum albumin (ALB); (I) hematoxylin and eosin (H&E) stain ing of liver sections (scale bar: 200 μm); (J) oil red O staining of liver sections (scale bar: 200 μm). n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Journal: Genes & nutrition

Article Title: Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism.

doi: 10.1186/s12263-024-00754-5

Figure Lengend Snippet: Fig. 3 Nogo-B deficiency mitigates liver lipid accumulation and liver injury in NAFLD model mice. (A) Serum triacylglycerol (TG); (B) serum total cholester ol (TC); (C) serum low-density lipoprotein cholesterol (LDL-C); (D) serum high-density lipoprotein cholesterol (HDL-C); (E) serum alanine aminotransferase (ALT); (F) serum aspartate aminotransferase (AST); (G) serum alkaline phosphatase (ALP); (H) serum albumin (ALB); (I) hematoxylin and eosin (H&E) stain ing of liver sections (scale bar: 200 μm); (J) oil red O staining of liver sections (scale bar: 200 μm). n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Article Snippet: Following an 8-week period of standard growth, 12 WT mice and 12 Nogo-B−/− mice were randomly divided into the normal chow diet (NCD) or high-fat diet (HFD) groups, which were reared in a barrier system at temperatures ranging from 20 to 26 °C and fed either the NCD (SPF (Beijing) Biotechnology Co., Ltd.) or HFD (fat diet with 60 kcal%, MP Biomedicals, LLC) for 12 weeks.

Techniques: Staining

Fig. 4 Nogo-B deficiency attenuates inflammation in the livers of NAFLD model mice. (A) The concentration of interleukin-6 (IL-6); (B) the concentration of tumor necrosis factor-α (TNF-α); (C) the mRNA expression of tumor necrosis factor-α (TNF-α); (D) the mRNA expression of monocyte chemoattractant protein-1 (MCP1); (E) the mRNA expression of CD80; (F) the mRNA expression of CD86; (G) the mRNA expression of arginase-1 (Arg1); (H) the mRNA ex pression of arginase-1 (Arg1); (I) the mRNA expression of macrophage galactose N-acetyl-galactosamine specific lectin-2 (Mgl2); (J) the mRNA expression of resistin-like alpha (Retlna). n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Journal: Genes & nutrition

Article Title: Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism.

doi: 10.1186/s12263-024-00754-5

Figure Lengend Snippet: Fig. 4 Nogo-B deficiency attenuates inflammation in the livers of NAFLD model mice. (A) The concentration of interleukin-6 (IL-6); (B) the concentration of tumor necrosis factor-α (TNF-α); (C) the mRNA expression of tumor necrosis factor-α (TNF-α); (D) the mRNA expression of monocyte chemoattractant protein-1 (MCP1); (E) the mRNA expression of CD80; (F) the mRNA expression of CD86; (G) the mRNA expression of arginase-1 (Arg1); (H) the mRNA ex pression of arginase-1 (Arg1); (I) the mRNA expression of macrophage galactose N-acetyl-galactosamine specific lectin-2 (Mgl2); (J) the mRNA expression of resistin-like alpha (Retlna). n = 6. #P < 0.05, ##P < 0.01, ###P < 0.001; *P < 0.05, **P < 0.01, ***P < 0.001. WT, wild-type; NCD, normal chow diet; HFD, high-fat diet

Article Snippet: Following an 8-week period of standard growth, 12 WT mice and 12 Nogo-B−/− mice were randomly divided into the normal chow diet (NCD) or high-fat diet (HFD) groups, which were reared in a barrier system at temperatures ranging from 20 to 26 °C and fed either the NCD (SPF (Beijing) Biotechnology Co., Ltd.) or HFD (fat diet with 60 kcal%, MP Biomedicals, LLC) for 12 weeks.

Techniques: Concentration Assay, Expressing

Fig. 6 Nogo-B deficiency regulates serum metabolites in NAFLD model mice. (A) Principal component analysis (PCA) score plot; (B) partial least squares discriminant analysis (PLS-DA) score plot; (C) orthogonal partial least squares discriminant analysis (OPLS-DA) score plot; (D) OPLS-DA permutation test; (E) volcano plot, in which the red spots represent the significantly upregulated metabolites (log2FC > 0), the blue spots represent the significantly down regulated metabolites (log2FC < 0), and the gray spots represent the nonsignificant metabolites (P > 0.05); (F) clustered heatmap and VIP value bar graphs of differentially abundant metabolites (top 30 VIP values) between the WT-HFD and Nogo-B−/−-HDF groups; (G) KEGG pathways (top 20 enrichment ra tios) of differentially abundant metabolites. n = 5. VIP, variable importance in the projection; WT, wild-type mice; NCD, normal chow diet; HFD, high-fat diet

Journal: Genes & nutrition

Article Title: Protective effects of Nogo-B deficiency in NAFLD mice and its multiomics analysis of gut microbiology and metabolism.

doi: 10.1186/s12263-024-00754-5

Figure Lengend Snippet: Fig. 6 Nogo-B deficiency regulates serum metabolites in NAFLD model mice. (A) Principal component analysis (PCA) score plot; (B) partial least squares discriminant analysis (PLS-DA) score plot; (C) orthogonal partial least squares discriminant analysis (OPLS-DA) score plot; (D) OPLS-DA permutation test; (E) volcano plot, in which the red spots represent the significantly upregulated metabolites (log2FC > 0), the blue spots represent the significantly down regulated metabolites (log2FC < 0), and the gray spots represent the nonsignificant metabolites (P > 0.05); (F) clustered heatmap and VIP value bar graphs of differentially abundant metabolites (top 30 VIP values) between the WT-HFD and Nogo-B−/−-HDF groups; (G) KEGG pathways (top 20 enrichment ra tios) of differentially abundant metabolites. n = 5. VIP, variable importance in the projection; WT, wild-type mice; NCD, normal chow diet; HFD, high-fat diet

Article Snippet: Following an 8-week period of standard growth, 12 WT mice and 12 Nogo-B−/− mice were randomly divided into the normal chow diet (NCD) or high-fat diet (HFD) groups, which were reared in a barrier system at temperatures ranging from 20 to 26 °C and fed either the NCD (SPF (Beijing) Biotechnology Co., Ltd.) or HFD (fat diet with 60 kcal%, MP Biomedicals, LLC) for 12 weeks.

Techniques: